Consolidated Statement of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Convertible Preferred Stock Preferred Stock
Beginning balance (in shares) at Dec. 31, 2021						1,250
Beginning balance at Dec. 31, 2021	$ 179,746,436	$ 70,359	$ 351,033,589	$ 0	$ (171,357,513)	$ 1
Beginning balance (in shares) at Dec. 31, 2021		70,364,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and employee stock purchase plan (in shares)		101,973
Issuance of common stock from exercise of stock options and employee stock purchase plan	180,658	$ 108	180,550
Stock-based compensation expense	6,556,686		6,556,686
Other comprehensive income	(42,187)			(42,187)
Net loss	$ (54,169,029)				(54,169,029)
Ending balance (in shares) at Dec. 31, 2022	1,250					1,250
Ending balance at Dec. 31, 2022	$ 132,272,564	$ 70,467	357,770,825	(42,187)	(225,526,542)	$ 1
Ending balance (in shares) at Dec. 31, 2022	70,466,885	70,466,885
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and employee stock purchase plan (in shares)		225,107
Issuance of common stock from exercise of stock options and employee stock purchase plan	$ 535,201	$ 225	534,976
Stock-based compensation expense	7,285,192		7,285,192
Other comprehensive income	42,889			42,889
Net loss	$ (52,338,959)				(52,338,959)
Ending balance (in shares) at Dec. 31, 2023	1,250					1,250
Ending balance at Dec. 31, 2023	$ 87,796,887	$ 70,692	$ 365,590,993	$ 702	$ (277,865,501)	$ 1
Ending balance (in shares) at Dec. 31, 2023	70,691,992	70,691,992